Search research articles
Contact Us
Filters
Showing results (81-90 of 308) with videos related to
Page
of 31
Sort By:
American Journal of Clinical Pathology
|
November 13, 2014
p16INK4a immunohistochemistry in cervical biopsy specimens: A systematic review and meta-analysis of the interobserver agreement
Miriam Reuschenbach, Nicolas Wentzensen, Maaike G Dijkstra, et al.
The Journal of Molecular Diagnostics : JMD
|
February 5, 2022
Clinical Performance of the Full Genotyping Agena MassARRAY HPV Assay Using SurePath Screening Samples within the VALGENT4 Framework
Helle Pedersen, Ditte M Ejegod, Wim Quint, et al.
Plos One
|
September 16, 2011
Triage of women with low-grade cervical lesions--HPV mRNA testing versus repeat cytology
Sveinung Wergeland Sørbye, Marc Arbyn, Silje Fismen, et al.
Plos One
|
October 15, 2011
HPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy
Sveinung Wergeland Sørbye, Marc Arbyn, Silje Fismen, et al.
Acta Cytologica
|
August 18, 2015
Retrospective Rescreening of Negative Cervical Cytology Samples Preceding Histologically Proven CIN2-3 and Squamous Cell Carcinoma: An Educational Opportunity to Understand and Prevent Laboratory Errors
Francesco Feoli, Christine Renard, Meryme Abouyahia, et al.
The Lancet Regional Health. Europe
|
March 4, 2022
HPV testing of self-samples: Influence of collection and sample handling procedures on clinical accuracy to detect cervical precancer
Marc Arbyn, Ardashel Latsuzbaia, Philip E Castle, et al.
Journal of Clinical Microbiology
|
November 15, 2019
Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework
Jesper Hansen Bonde, Helle Pedersen, Wim Quint, et al.
European Journal of Public Health
|
September 29, 2018
The legal framework for European cervical cancer screening programmes
Ondřej Májek, Ahti Anttila, Marc Arbyn, et al.
Journal of Clinical Microbiology
|
March 1, 2013
Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities
Markus Schmitt, Christophe Depuydt, Ina Benoy, et al.
International Journal of Cancer
|
October 5, 2012
Prevalence and viral load of 51 genital human papillomavirus types and three subtypes
Markus Schmitt, Christophe Depuydt, Ina Benoy, et al.
Page
of 31
Search research articles
Search
Showing results (81-90 of 308) with videos related to
Sort By:
Page
of 31
American Journal of Clinical Pathology
|
November 13, 2014
p16INK4a immunohistochemistry in cervical biopsy specimens: A systematic review and meta-analysis of the interobserver agreement
Miriam Reuschenbach, Nicolas Wentzensen, Maaike G Dijkstra, et al.
The Journal of Molecular Diagnostics : JMD
|
February 5, 2022
Clinical Performance of the Full Genotyping Agena MassARRAY HPV Assay Using SurePath Screening Samples within the VALGENT4 Framework
Helle Pedersen, Ditte M Ejegod, Wim Quint, et al.
Plos One
|
September 16, 2011
Triage of women with low-grade cervical lesions--HPV mRNA testing versus repeat cytology
Sveinung Wergeland Sørbye, Marc Arbyn, Silje Fismen, et al.
Plos One
|
October 15, 2011
HPV E6/E7 mRNA testing is more specific than cytology in post-colposcopy follow-up of women with negative cervical biopsy
Sveinung Wergeland Sørbye, Marc Arbyn, Silje Fismen, et al.
Acta Cytologica
|
August 18, 2015
Retrospective Rescreening of Negative Cervical Cytology Samples Preceding Histologically Proven CIN2-3 and Squamous Cell Carcinoma: An Educational Opportunity to Understand and Prevent Laboratory Errors
Francesco Feoli, Christine Renard, Meryme Abouyahia, et al.
The Lancet Regional Health. Europe
|
March 4, 2022
HPV testing of self-samples: Influence of collection and sample handling procedures on clinical accuracy to detect cervical precancer
Marc Arbyn, Ardashel Latsuzbaia, Philip E Castle, et al.
Journal of Clinical Microbiology
|
November 15, 2019
Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework
Jesper Hansen Bonde, Helle Pedersen, Wim Quint, et al.
European Journal of Public Health
|
September 29, 2018
The legal framework for European cervical cancer screening programmes
Ondřej Májek, Ahti Anttila, Marc Arbyn, et al.
Journal of Clinical Microbiology
|
March 1, 2013
Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities
Markus Schmitt, Christophe Depuydt, Ina Benoy, et al.
International Journal of Cancer
|
October 5, 2012
Prevalence and viral load of 51 genital human papillomavirus types and three subtypes
Markus Schmitt, Christophe Depuydt, Ina Benoy, et al.
Page
of 31